<DOC>
	<DOCNO>NCT00603811</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity VAX102 [ Flagellin.HuM2e ] , recombinant , inactivate , subunit influenza vaccine give two dose regimen range dos .</brief_summary>
	<brief_title>Phase I Safety Immunogenicity Study VAX102 Flagellin.HuM2e Influenza Vaccine Healthy Adults</brief_title>
	<detailed_description>VAX102 cross-protective influenza A vaccine base recombinant protein express E. coli . The protein comprise Salmonella typhimurium flagellin type 2 ( STF2 ; TLR5 ligand ) fuse Human M2e . The active component VAX102 vaccine manufacture standard fermentation process . Unlike HA NA viral protein , amino acid sequence M2e remain remarkably stable human influenza A virus isolate . Thus influenza vaccine base M2e antigen could elicit cross-protective immunity human influenza A virus strain . VAX102 vaccine relies single cross-reactive influenza A virus antigen manufacture recombinant protein fermentation-production process .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adult age 1849 year inclusive provide write informed consent participate . Comprehension study requirement , express availability require study period , ability attend schedule visit . Presence significant acute chronic , uncontrolled medical psychiatric illness Documented influenza infection 6 month prior study entry . Presently receive history receive medication treatment affect immune system Acute disease within 72 hour prior vaccination Investigational product ( test article ) administration occur Days 0 28 ( ± 3 ) . Inclinic safety evaluation perform screening , test article dose , Days 1 , 7 ( ± 2 ) , 14 ( ± 2 ) , 29 , 35 ( ± 2 ) , 42 ( ± 2 ) , 60 ( ± 2 ) , 120 ( ± 7 ) , 180 ( ± 7 ) . Completion Memory Aid seven day follow vaccine dose request subject use accurate recall local systemic reaction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Influenza vaccine</keyword>
	<keyword>M2e</keyword>
</DOC>